According to the
report analysis, ‘Global Next-Generation Sequencing (NGS)
Market 2018-2024’ states that there are several key players
which are presently functioning in this market more actively for leading the
fastest market growth and attaining the highest market share across the globe
in the short span of time by adopting the efficient strategies and policies of
doing work and improving the specification of this which further being able to
deliver beneficial information with the excess of new applications to the
researchers for study the biological systems includes Illumina, Inc., Thermo
Fisher Scientific, Inc., Pacific Biosciences of California, Oxford Nanopore
Technologies Limited, Beijing Genomics Institute, Agilent Technologies, Inc.,
Qiagen N.V., Eurofins Scientific, F. Hoffmann-La Roche, DNASTAR, Inc.,
Biomatters Limited and other predominate and niche players. Moreover, the key
players of this market are investing the huge amount of money in the research
and development programs for developing the applications of this which further
proved to be profitable for generating the high amount of revenue and leading
the market growth more significantly in the short span of time with the high
amount of market share around the globe.

The next-generation
sequencing is abbreviated by NGS and is the enormously parallel sequencing
technology that has developed the biological sciences. With its ultra-high
throughput, speed and scalability, NGS allows the researcher to function a huge
change of the applications and study the biological systems at a level never
before possible. Furthermore, the key players of this market are playing an
important role by doing effective developments and adoption of techniques of
doing work while, the significant development in the technology is also taken
place which provide better results to the researchers and proved to be
beneficial for leading the fastest market growth in the coming years.

The Global
Next-Generation Sequencing market is projected to observe a significant CAGR of
18.6% during the forecast period of 2018-2024.  Whereas, with the
effective developments in the specification and working of the key players the
market is spread across the globe more positively which proficiently includes North
America, Europe, Asia Pacific, and Rest of the World (ROW). Meanwhile, the
North America is the prominent shareholder in the global next-generation
sequencing market, followed by Europe. Asia-Pacific region is anticipated to
increase at high CAGR during the forecasted period owing to increasing funding for
healthcare research, developing the patient pool, and rising healthcare expenditure.
The markets in developing counties such as, India, China and Brazil are
anticipated to rise at a rapid pace for next five years.

Presently, the
next-generation sequencing market is associated with few key companies owing to
the contribution of complicated technologies and the prerequisite of high
capital investment. Sequencing based test may soon be viewed as the gold
standard in the field of molecular diagnostics. The upsurge in the applications
of NGS has made many biotechnological firms and diagnostic laboratories to
invest profoundly in this field by introducing new products or attaining the
other smaller firms or by partnership. Therefore, in the near future, it is
expected that the market of next generation sequencing will increase across the
globe more significantly over the recent few years.

To know more, click on the link below:

https://www.kenresearch.com/healthcare/general-healthcare/next-generation-sequencing/173244-91.html

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

Sales@kenresearch.com

+91-9015378249